Skip to content

Clinical trials

Completed Myocardial Infarction trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Infarction Status: Completed Country / region: China Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20061
20071
20083
20091
20102
20113
20122
20133
20142
20153
20163
20173
20183
20192
20203
20212
20221
20234
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed46

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese PLA General Hospital4
Medtronic Vascular3
AstraZeneca2
Beijing Luhe Hospital2
Boehringer Ingelheim2
Novartis Pharmaceuticals2
Qilu Hospital of Shandong University2
RenJi Hospital2
Shanghai 10th People's Hospital2
The Affiliated Hospital of Xuzhou Medical University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Infarction46
Coronary Artery Disease9
Stroke8
Acute Coronary Syndrome6
Cardiovascular Diseases6
Myocardial Ischemia6
ST Elevation Myocardial Infarction5
Angina, Unstable3
Arteriosclerosis3
Atrial Fibrillation3

Trials

Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.